- Stocks
- Pharma & Healthcare
- Medi-Caps
Medi-Caps share price
NSE: MEDICAPQPharma & HealthcareReal Estate - Diversified
Medi-Caps at a glance
Medi-Caps (NSE: MEDICAPQ) closed at ₹25.50 on 21 Oct 2026. With a market capitalisation of ₹32 Cr, it ranks 3341st by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Real Estate - Diversified.
Its return on equity was −2.7% in FY26. Its 52-week range is ₹20.33 (18 Aug 2026) to ₹36.80 (10 Sep 2026); the last close is 30.7% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹3 Cr (+3.7% year on year) and net profit −₹2 Cr, on a consolidated basis. Promoters held 51.44% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹32 CrRank 3341 on NSE
- Price to book
- 0.26×FY26
- EPS (TTM)
- −₹1.42to Q1 FY27
- ROE
- −2.7%FY26
- ROCE
- −2.7%FY26
- Debt to equity
- 0FY26
- Net profit margin
- −24.4%FY26
- Book value / share
- ₹89.50FY26
- 52-week high
- ₹36.8010 Sep 2026
- 52-week low
- ₹20.3318 Aug 2026
- RSI (14-day)
- 48.9
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | +2.00% | −2.2% | −1.2% | — | — |
Medi-Caps quarterly results
| Quarter | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹8 Cr | ₹4 Cr | ₹7 Cr | ₹3 Cr | ₹2 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr |
| Revenue YoY | +37.6% | −43.1% | −11.8% | −56.5% | −75.8% | +7.0% | −50.3% | +3.7% |
| Net profit | ₹0 Cr | −₹2 Cr | ₹2 Cr | −₹3 Cr | −₹2 Cr | −₹1 Cr | ₹3 Cr | −₹2 Cr |
| Net profit YoY | +158.3% | — | — | — | −687.1% | — | +76.7% | — |
| Net margin | 3.7% | −51.0% | 24.8% | −129.7% | −90.5% | −17.9% | 88.1% | −79.9% |
| EPS | ₹0.25 | −₹1.64 | ₹1.38 | −₹2.80 | −₹1.46 | −₹0.61 | ₹2.44 | −₹1.79 |
Medi-Caps financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹57 Cr | ₹70 Cr | ₹49 Cr | ₹27 Cr | ₹25 Cr | — |
| Operating profit | ₹11 Cr | ₹10 Cr | ₹5 Cr | −₹1 Cr | −₹1 Cr | — |
| Net profit | ₹11 Cr | ₹10 Cr | ₹2 Cr | −₹2 Cr | −₹1 Cr | — |
| EPS (₹) | ₹11.00 | ₹8.00 | ₹1.00 | −₹2.00 | ₹0.00 | — |
| Cash from operations | ₹15 Cr | ₹7 Cr | −₹6 Cr | ₹7 Cr | ₹5 Cr | — |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹105 Cr | ₹116 Cr | ₹119 Cr | ₹121 Cr | ₹121 Cr | ₹112 Cr |
Medi-Caps shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 50.77% | 50.77% | 50.77% | 50.76% | 51.36% | 51.44% |
| Domestic institutions | 0.03% | 0.03% | 0.03% | 0.02% | 0.02% | 0.02% |
| Non-institutions | 49.20% | 49.20% | 49.20% | 49.22% | 48.61% | 48.54% |
Medi-Caps vs peers
The listed Pharma & Healthcare companies nearest to Medi-Caps by market capitalisation.
Ask anything about Medi-Caps
Pivot answers on the live chart with evidence you can check, and tests strategies against MEDICAPQ's own history. Try: “Why has MEDICAPQ moved over the last three months?” · “Backtest a 50-day moving-average crossover on MEDICAPQ over five years” · “Compare MEDICAPQ with JFLLIFE on margins and valuation”
Frequently asked questions about Medi-Caps
What is the share price of Medi-Caps today?
Medi-Caps (NSE: MEDICAPQ) last closed at ₹25.50 on 21 Oct 2026. Its 52-week high is ₹36.80 and its 52-week low is ₹20.33.
What is the market cap of Medi-Caps?
Medi-Caps' market capitalisation is ₹32 Cr (₹32 Cr) at the 22 Oct 2026 close, ranking 3341st among the NSE companies Pivot tracks.
What is the ROE and ROCE of Medi-Caps?
Return on equity was −2.7% in FY26 and return on capital employed was −2.7% in FY26 (consolidated figures).
Is Medi-Caps a debt-free company?
Medi-Caps is close to debt-free: its debt-to-equity ratio was 0 in FY26.
What were Medi-Caps' latest quarterly results?
For Q1 FY27 (quarter ended 30 Jun 2026), Medi-Caps reported revenue of ₹3 Cr, +3.7% year on year, and net profit of −₹2 Cr.
What is the shareholding pattern of Medi-Caps?
As of 30 Jun 2026: promoters 51.44%, domestic institutions 0.02%, non-institutions 48.54%.
Who are Medi-Caps' competitors?
The listed Pharma & Healthcare companies closest to Medi-Caps by market cap are JFL Life Scienc, Chandra Bhagat, Sharma East Ind, Deccan Health C, KK Shah Hospita and Panjon.
Is Medi-Caps a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Medi-Caps' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on MEDICAPQ against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 21 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with M · all NSE stocks · this page as text